EFIV | SPY | EFIV / SPY | |
Gain YTD | 9.629 | 10.276 | 94% |
Net Assets | 1.14B | 655B | 0% |
Total Expense Ratio | 0.10 | 0.09 | 106% |
Turnover | 12.00 | 3.00 | 400% |
Yield | 1.15 | 1.13 | 102% |
Fund Existence | 5 years | 33 years | - |
EFIV | SPY | |
---|---|---|
RSI ODDS (%) | 4 days ago63% | 1 day ago70% |
Stochastic ODDS (%) | 4 days ago63% | 1 day ago74% |
Momentum ODDS (%) | 4 days ago85% | 1 day ago90% |
MACD ODDS (%) | 4 days ago59% | 1 day ago70% |
TrendWeek ODDS (%) | 4 days ago88% | 1 day ago75% |
TrendMonth ODDS (%) | 4 days ago86% | 1 day ago86% |
Advances ODDS (%) | 13 days ago86% | 12 days ago87% |
Declines ODDS (%) | 5 days ago73% | 5 days ago75% |
BollingerBands ODDS (%) | 4 days ago69% | 1 day ago86% |
Aroon ODDS (%) | 4 days ago84% | 1 day ago82% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HIBS | 7.64 | 0.09 | +1.19% |
Direxion Daily S&P 500® Hi Bt Br 3X ETF | |||
CCD | 20.31 | 0.02 | +0.10% |
Calamos Dynamic Convertible & Income Fund | |||
SJNK | 25.48 | -0.04 | -0.16% |
SPDR® Blmbg ST HY Bd ETF | |||
HDUS | 62.27 | -0.11 | -0.17% |
Hartford Disciplined US Equity ETF | |||
THNR | 22.87 | -0.28 | -1.20% |
Amplify Weight Loss Drug & Treatment ETF |
A.I.dvisor indicates that over the last year, EFIV has been closely correlated with AXP. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if EFIV jumps, then AXP could also see price increases.
Ticker / NAME | Correlation To EFIV | 1D Price Change % | ||
---|---|---|---|---|
EFIV | 100% | +1.48% | ||
AXP - EFIV | 82% Closely correlated | +3.57% | ||
PH - EFIV | 81% Closely correlated | +2.63% | ||
GS - EFIV | 81% Closely correlated | +3.62% | ||
DOV - EFIV | 80% Closely correlated | +3.19% | ||
EMR - EFIV | 79% Closely correlated | +2.83% | ||
More |